Geron Corporation (GERN) Social Stream



Geron Corporation (GERN): $1.05

-0.03 (-2.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add GERN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Geron Corp (GERN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Geron Corp.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $7 $3 $4.5 $1.26 257.14%

The Trend in the Analyst Price Target


GERN's average price target has moved up $0.5 over the prior 31 weeks.

Over the past 18 months, GERN's average upside potential has been 175.11%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-16 4 7 3 4.5 1.51 198.01%
2020-05-29 3 4 3 3.6 NA NA%

GERN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 20 months, GERN's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GERN as an investment opportunity.

  • Geron Corp's average analyst price target is greater than 2.65% of all US stocks.
  • Geron Corp's upside potential (average analyst target price relative to current price) is greater than 93.04% of all US stocks.
  • GERN has a less variance in analysts' estimates than 8.81999999999999% of all US stocks.
  • The number of analysts covering the stock of GERN is higher than 23.35% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Geron Corp are EFTR, PSTX and CNCE.

What is the outlook for GERN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7443 seconds.